Decrease in platelet count in patients with AKI and its association with major adverse kidney events

dc.contributor.authorRamón Medina-González
dc.contributor.authorJosé J. Zaragoza
dc.contributor.authorEduardo M. Hernández-Barajas
dc.contributor.authorJuarez Correa-de Leon
dc.contributor.authorRolando Claure‐Del Granado
dc.contributor.authorArmando Vázquez-Rangel
dc.contributor.authorLiliana M. Pineda-Segura
dc.contributor.authorMartha K. Franco-Garcia
dc.contributor.authorGael Chávez-Alonso
dc.contributor.authorJuan A Gómez-Fregoso
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:21:36Z
dc.date.available2026-03-22T14:21:36Z
dc.date.issued2024
dc.descriptionCitaciones: 10
dc.description.abstractIn our retrospective cohort of patients with AKI, <i>a</i> > 21% reduction in platelet count was associated with MAKE. Our results are useful for generating hypotheses and motivating us to continue studying this association with a more robust design.
dc.identifier.doi10.1080/0886022x.2024.2359643
dc.identifier.urihttps://doi.org/10.1080/0886022x.2024.2359643
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/46053
dc.language.isoen
dc.publisherTaylor & Francis
dc.relation.ispartofRenal Failure
dc.sourceHospital Civil de Guadalajara
dc.subjectMedicine
dc.subjectAcute kidney injury
dc.subjectInternal medicine
dc.subjectPlatelet
dc.subjectAdverse effect
dc.subjectKidney disease
dc.subjectKidney
dc.titleDecrease in platelet count in patients with AKI and its association with major adverse kidney events
dc.typearticle

Files